Senior Vice President/President of Global R&D, Hengrui Medicine
Dr. Lianshan Zhang graduated from China Pharmaceutical University with a bachelor degree in Medicinal Chemistry and went abroad to continue his study at University of Tübingen in Germany and obtained his PhD in Organic Chemistry. After graduation, he went to the Department of Microbiology & Immunology at Vanderbilt University as a Post-Doctoral Fellow.
Before joining Hengrui Medicine, Dr. Zhang has held vital positions in several world-renowned pharmaceutical companies. He was the Senior Chemist, the Principal Research Scientist and Senior Director of Chemistry in Eli Lily and Marcadia Biotech. He has been engaged in peptide methodology and drug development for more than 30 years since 1988 and has accomplished remarkable achievements in the development of anti-diabetic drugs.
He is now the VP and President of Global R&D of Hengrui Medicine, leading the R&D teams to develop series of internationally competitive and innovative drugs covering prominent targets along with therapeutic areas that have with huge unmet clinical needs.